HSHHSH Health Technology Supplier Hub
Home › Suppliers › Innovaccer › Risk

Innovaccer: risk summary

Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.

Financial

Latest full-year results from official filings.

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Researched 8 Nov 2026

Adverse media

Credible news about incidents, disputes, legal action or restructuring in the last 24 months.

May 2026: Innovaccer confirmed it had laid off 340 employees across India and the US in a 'global organisational change' as it shifts to an AI-focused operating model.

Researched 10 Nov 2026

Cyber & information governance

Data breaches, cyber incidents, regulator action and assurance status.

No data breaches, cyber incidents or regulator action involving Innovaccer found in HSH's search of the last 24 months. NHS DSPT status not yet checked.

Researched 10 Nov 2026

Regulatory & clinical safety

Recalls, safety notices, regulator action and clinical safety concerns.

Data platform and analytics software supplier; no regulatory or clinical safety actions found in the last 24 months.

Researched 10 Nov 2026

Contract performance

Contract delivery, go-lives, terminations and disputes.

Aug 2026: Innovaccer named Mastek a platinum global systems integrator to deploy its Gravity platform across the US, UK, Europe and Middle East. Jan 2025: it raised $275m in Series F funding. No troubled implementations or disputes found.

Researched 10 Nov 2026